EUVIMEDEUVIMED entdecken
Crossref

Multi-omics analysis identified ASRGL1 as a novel oncogene and potential therapeutic target in prostate cancer

Yuan Ma, Rong Fan, Wenyue Yu, Kefei Duan, Gaoteng Lin, Zheng Chen, Guizhong Li

American Journal of Clinical and Experimental Urology · 2026 · 14 (5) · 189-203

DOI: 10.62347/bumq2278 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Clinical and Experimental Urology, 2026. Verfasst von Yuan Ma und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Ma, Y., Fan, R., Yu, W., Duan, K., Lin, G., Chen, Z., & Li, G. (2026). Multi-omics analysis identified ASRGL1 as a novel oncogene and potential therapeutic target in prostate cancer. American Journal of Clinical and Experimental Urology, 14(5), 189-203. https://doi.org/10.62347/bumq2278

Vancouver

Ma Y, Fan R, Yu W, Duan K, Lin G, Chen Z, et al. Multi-omics analysis identified ASRGL1 as a novel oncogene and potential therapeutic target in prostate cancer. American Journal of Clinical and Experimental Urology. 2026;14(5):189-203. doi:10.62347/bumq2278

BibTeX
@article{Ma2026,
  author = {Ma, Yuan and Fan, Rong and Yu, Wenyue and Duan, Kefei and Lin, Gaoteng and Chen, Zheng and Li, Guizhong},
  title = {Multi-omics analysis identified ASRGL1 as a novel oncogene and potential therapeutic target in prostate cancer},
  journal = {American Journal of Clinical and Experimental Urology},
  year = {2026},
  volume = {14},
  number = {5},
  pages = {189--203},
  doi = {10.62347/bumq2278}
}
Kostenlos starten →